Cancer-associated fibroblasts in hepatocellular carcinoma
- PMID: 27570421
- PMCID: PMC4974583
- DOI: 10.3748/wjg.v22.i30.6841
Cancer-associated fibroblasts in hepatocellular carcinoma
Abstract
The hepatic stellate cells in the liver are stimulated sustainably by chronic injury of the hepatocytes, activating myofibroblasts, which produce abundant collagen. Myofibroblasts are the major source of extracellular proteins during fibrogenesis, and may directly, or secreted products, contribute to carcinogenesis and tumor progression. Cancer-associated fibroblasts (CAFs) are one of the components of the tumor microenvironment that promote the proliferation and invasion of cancer cells by secreting various growth factors and cytokines. CAFs crosstalk with cancer cells stimulates tumor progression by creating a favorable microenvironment for progression, invasion, and metastasis through the epithelial-mesenchymal transition. Basic studies on CAFs have advanced, and the role of CAFs in tumors has been elucidated. In particular, for hepatocellular carcinoma, carcinogenesis from cirrhosis is a known fact, and participation of CAFs in carcinogenesis is supported. In this review, we discuss the current literature on the role of CAFs and CAF-related signaling in carcinogenesis, crosstalk with cancer cells, immunosuppressive effects, angiogenesis, therapeutic targets, and resistance to chemotherapy. The role of CAFs is important in cancer initiation and progression. CAFtargeted therapy may be effective for suppression not only of fibrosis but also cancer progression.
Keywords: Cancer associated fibroblast; Hepatic stellate cell; Hepatocellular carcinoma; Immunosuppression; Therapeutic target.
Figures

Similar articles
-
The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.Int J Mol Sci. 2019 Apr 7;20(7):1723. doi: 10.3390/ijms20071723. Int J Mol Sci. 2019. PMID: 30959975 Free PMC article. Review.
-
Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.Int J Mol Sci. 2023 Feb 15;24(4):3941. doi: 10.3390/ijms24043941. Int J Mol Sci. 2023. PMID: 36835352 Free PMC article. Review.
-
FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.Cancer Lett. 2018 Mar 28;417:21-34. doi: 10.1016/j.canlet.2017.12.021. Epub 2017 Dec 15. Cancer Lett. 2018. PMID: 29248714
-
Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.Liver Int. 2014 Jul;34(6):834-43. doi: 10.1111/liv.12465. Epub 2014 Feb 12. Liver Int. 2014. PMID: 24397349 Review.
-
Inducible factors for cancer-associated fibroblasts in liver cancer versus myofibroblasts in inflammatory liver disease.Histol Histopathol. 2016 Feb;31(2):141-8. doi: 10.14670/HH-11-668. Epub 2015 Sep 23. Histol Histopathol. 2016. PMID: 26398776 Review.
Cited by
-
CAFrgDB: a database for cancer-associated fibroblasts related genes and their functions in cancer.Cancer Gene Ther. 2023 Jun;30(6):917-925. doi: 10.1038/s41417-023-00603-4. Epub 2023 Mar 15. Cancer Gene Ther. 2023. PMID: 36922546 Free PMC article.
-
Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis.Front Immunol. 2022 Jan 4;12:795372. doi: 10.3389/fimmu.2021.795372. eCollection 2021. Front Immunol. 2022. PMID: 35058933 Free PMC article. Review.
-
The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.Cancers (Basel). 2020 Mar 29;12(4):823. doi: 10.3390/cancers12040823. Cancers (Basel). 2020. PMID: 32235370 Free PMC article. Review.
-
Mitochondrial Dysfunction-Molecular Mechanisms and Potential Treatment approaches of Hepatocellular Carcinoma.Mol Cell Biochem. 2025 Apr;480(4):2131-2142. doi: 10.1007/s11010-024-05144-4. Epub 2024 Oct 27. Mol Cell Biochem. 2025. PMID: 39463200 Review.
-
Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.Cancer Sci. 2019 Jan;110(1):334-344. doi: 10.1111/cas.13847. Epub 2018 Dec 13. Cancer Sci. 2019. PMID: 30353606 Free PMC article.
References
-
- De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 2008;123:2229–2238. - PubMed
-
- Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349–363. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical